Disha, formerly Curelink, raises $4.6M Series A led by General Catalyst
What's the deal? DishaDealroom has a profile for this one. Try Dealroom →, the AI-powered health coaching platform formerly known as CurelinkDealroom has a profile for this one. Try Dealroom →, has raised US$5.96M in a Series A round led by General Catalyst. Existing investor Elevation CapitalDealroom has a profile for this one. Try Dealroom → and Flamel Performing Creatives Private Limited also participated.
General Catalyst put in US$5.19M, Elevation Capital added US$706.2K, and Flamel contributed US$65.2K, according to regulatory filings accessed by Entrackr.
What's the endgame? Disha offers personalised diet, fitness, and chronic-care support across 15 conditions in Hindi, English, and Hinglish, with round-the-clock coaching. It claims 70 lakh sign-ups, 3 lakh active users, and 1.4 crore messages exchanged.
The fresh capital will fund working capital, AI model development, and business expansion, the filings indicate.
By the numbers: The round lifted Disha's post-money valuation about 52% to roughly US$39.1M, up from US$25.8M previously. The startup had earlier raised $3.5 million in a seed round led by Elevation Capital and Venture HighwayDealroom has a profile for this one. Try Dealroom →.
What about the financials? Disha's revenue doubled to US$666.8K in FY25 from US$335.4K in FY24, while its loss narrowed 22.5% to US$604.3K from US$779.5K. FY26 numbers are not yet reported.
Who owns what? Founders Aman Singla and Divyansh Jain each hold 31.10%. General Catalyst holds 13.33% and Elevation Capital 9.96%. Angel backers include Paytm founder Vijay Shekhar Sharma and ShareChat cofounder Ankush Sachdeva, each with about 0.16%.
The signal: This is a modest Series A by global standards, but it reflects continued investor appetite for AI-driven, vernacular healthcare platforms targeting India's chronic-care market.
Read more: entrackr.com
Image credit: Generated with Gemini
